Depression

Depression Treatment

A complex neurobiological disorder — not a weakness. Arising from dysfunction in cortico-limbic
circuits and neurotransmitter systems, depression is entirely treatable with a personalised
combination of medications, neuroplasticity enhancement, and lifestyle intervention.

Depression-----0

TYPES WE TREAT

Primary

Major Depressive Disorder

Persistent low mood, anhedonia, and somatic symptoms affecting daily function for two or more weeks.

Resistant

Refractory Depression

Not responding to two or more antidepressant trials — a key indication for neuroplasticity enhancement.

Post-stroke

Post-Stroke Depression

Affects up to 40% of stroke survivors — requiring integrated neurological and psychiatric management.

Neurological

Parkinson's-related

A core non-motor feature driven by dopaminergic and serotonergic pathway degeneration.

Comorbid

Chronic Pain-related

Pain and depression share overlapping neural circuits — each worsening the other in a reinforcing cycle.

Comorbid

Anxiety & Mixed States

Depression frequently co-occurs with anxiety, requiring integrated management of both.

ASSESSMENT

Clinical Evaluation + Standardised Scales + Neurological Context

 Thorough clinical interview, PHQ-9/HAM-D severity rating, cognitive screening, thyroid and metabolic bloods, MRI
where indicated, and full medication history — combined to build a personalised treatment plan.

Treatment Protocol

Personalised layered approach — medications stabilise, neuroplasticity restores, lifestyle sustains
In neurological depression (post-stroke, Parkinson’s, chronic pain), medication selection and therapy parameters are
carefully personalised to avoid interactions and address the underlying neurological mechanisms.

We deliver targeted energy to the dorsolateral prefrontal cortex (DLPFC) — the key region implicated in mood
regulation. This promotes neuroplastic reorganisation of cortico-limbic circuits, restoring the prefrontal control over
limbic hyperactivity that drives depression. Particularly effective in treatment-resistant and neurological depression.
Non-invasive, no systemic side effects, and personalised to each patient.

Antidepressant & Adjunct Medications

SSRIs, SNRIs, and adjuncts are selected based on symptom profile, comorbidities, and prior response. In
neurological depression, medication is carefully tailored to the underlying disease — personalised to each patient’s full
clinical picture.

LAYER 3 — LIFESTYLE

Exercise

 Increases BDNF, serotonin, and dopamine — a proven antidepressant effect

Sleep hygiene Consistent

Sleep hygiene Consistent sleep scheduling regulates the stress axis and treatment response

Diet

 Anti-inflammatory nutrition supports the gut-brain axis
and reduces neuroinflammation

Mindfulness

 Reduces rumination and enhances prefrontal cortical regulation of mood

Recovery is a circuit to be restored — not a mood to be managed

With personalised medications, neuroplasticity enhancement, and sustained lifestyle change, patients experience meaningful improvement in mood, energy, sleep, and cognition. In neurological depression, our integrated approach addresses the condition at its biological root.

Practice Highlights
What Makes Our Practice Different
Personalised Protocols
Every plan tailored to the individual
Advanced Technology
Cutting-edge non-invasive therapeutic science
Mechanism-Based Care
We treat biology, not just symptoms
23+ Years Experience
Decades of specialist clinical wisdom
Whole Person Approach
Mind, body & lifestyle integrated
Objective Outcomes
Measurable results — not just relief

Mood Disorder Treatment

Mood Disorders

Mood disorders are complex mental health conditions that disrupt emotional stability, often leading to persistent sadness, irritability, or intense mood fluctuations. Common conditions include depression, bipolar disorder, and anxiety-related mood changes, all of which can significantly impact one’s personal,

Comprehensive Evaluation by Dr. Sreekanth Vemula

Every recovery journey begins with a detailed clinical and neurological assessment by Dr. Sreekanth Vemula, a senior neurophysician with over 26 years of experience in treating neurological and neuropsychiatric disorders.
 His evaluation includes:

  • In-depth review of medical and emotional history
  • Neurological and psychological function testing
  • Identification of biochemical or structural brain factors influencing mood

This precise assessment ensures an accurate diagnosis and a fully personalized care plan.

Integrated Mood Disorder Treatment Approach

Treatment is comprehensive and tailored to each patient’s needs.
 It may include:

  • Medication therapy for mood stabilization and symptom control
  • Psychotherapy and counseling for emotional regulation and coping skills
  • Lifestyle and stress-management programs to improve resilience
  • Neuromodulation therapies (when indicated) to balance brain activity and enhance emotional stability

For patients experiencing mood-related neurological symptoms such as muscle tension or dystonia, Botulinum Toxin (Botox) injections are available to improve comfort and mobility.